Elevated expression of RGS2 may underlie reduced olfaction in COVID-19 patients
Eden Avnat, View ORCID ProfileGuy Shapira, View ORCID ProfileDavid Gurwitz, View ORCID ProfileNoam Shomron
doi: https://doi.org/10.1101/2022.05.12.22274991
Eden Avnat
1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Guy Shapira
1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Edmond J Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel
David Gurwitz
1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel
Noam Shomron
1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Edmond J Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel
3Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel
Article usage
Posted May 16, 2022.
Elevated expression of RGS2 may underlie reduced olfaction in COVID-19 patients
Eden Avnat, Guy Shapira, David Gurwitz, Noam Shomron
medRxiv 2022.05.12.22274991; doi: https://doi.org/10.1101/2022.05.12.22274991
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2823)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12519)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4398)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2832)
- Health Policy (1044)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4156)
- Nursing (220)
- Nutrition (615)
- Oncology (2188)
- Ophthalmology (622)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1167)
- Primary Care Research (481)
- Public and Global Health (6739)
- Radiology and Imaging (1481)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)